Ledger.Open graph →
SEC Form D · filed February 11, 2022

Triana Biomedicines, Inc

Offering
$80.0M
Sold
$34.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Waltham, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Milind Deshpande · Waltham, MADirectorPatrick Trojer · Waltham, MAExec · DirectorShelley Chu · Waltham, MADirectorJoshua Resnick · Waltham, MADirectorSimon Read · Waltham, MADirectorDavid Grayzel · Waltham, MADirectorRonald Rosenfarb · CAROLINA, Puerto RicoDirectorRichard Y. Bilotti · Piedmont, CADirectorNathan Mcgill · Columbus, OHExec · DirectorEthan Y. Huynh · Piedmont, CADirectorMichael Esposito · Redondo Beach, CADirectorAndrew P. Walrath · Schenectady, NYDirectorTom B. Mccandless · Vancouver, British Columbia, CanadaDirectorJay A. Brammer · Carmel, INDirectorGrady J. Gaynor · Carmel, INDirectorOskar Lewnowski · New York, NYExec · DirectorJonathan Lamb · New York, NYDirectorPeter Rozenauers · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗